Travere Therapeutics, Inc.TVTXNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P10
Near historical low
vs 3Y Ago
-33.7x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -185.53% |
| Q3 2025 | 301.54% |
| Q2 2025 | 69.06% |
| Q1 2025 | 31.59% |
| Q4 2024 | -9.95% |
| Q3 2024 | 22.15% |
| Q2 2024 | 48.25% |
| Q1 2024 | -50.89% |
| Q4 2023 | -159.82% |
| Q3 2023 | 276.03% |
| Q2 2023 | 0.81% |
| Q1 2023 | -31.16% |
| Q4 2022 | 5.50% |
| Q3 2022 | -3.91% |
| Q2 2022 | 11.77% |
| Q1 2022 | -47.31% |
| Q4 2021 | -44.71% |
| Q3 2021 | 8.65% |
| Q2 2021 | 27.58% |
| Q1 2021 | 55.71% |
| Q4 2020 | -439.37% |
| Q3 2020 | 13.50% |
| Q2 2020 | -3326.24% |
| Q1 2020 | 102.67% |
| Q4 2019 | 17.08% |
| Q3 2019 | 5.71% |
| Q2 2019 | 5.55% |
| Q1 2019 | -449.66% |
| Q4 2018 | 86.33% |
| Q3 2018 | -144.15% |
| Q2 2018 | -21.50% |
| Q1 2018 | -4.31% |
| Q4 2017 | 0.99% |
| Q3 2017 | -34.51% |
| Q2 2017 | -19.29% |
| Q1 2017 | -28.91% |
| Q4 2016 | 76.82% |
| Q3 2016 | -176.90% |
| Q2 2016 | -219.50% |
| Q1 2016 | 554.27% |